Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction.

AIM To evaluate the effect of thienorphine on small intestinal transit in vivo and on guinea-pig ileum (GPI) contraction in vitro. METHODS The effects of thienorphine on intestinal transit were examined in mice and in isolated GPI. Buprenorphine and morphine served as controls. The distance traveled by the head of the charchol and the total length of the intestine were measured in vivo. Gastrointestinal transit was expressed as a percentage of the distance traveled by the head of the marker relative to the total length of the small intestine. The isolated GPI preparations were connected to an isotonic force transducer and equilibrated for at least 1 h before exposure to drugs. Acetylcholine was used for muscle stimulation. RESULTS Thienorphine (0.005-1.0 mg/kg, ig) or buprenorphine (0.005-1.0 mg/kg, sc) dose-dependently significantly inhibited gut transit compared with saline. Thienorphine inhibited gut transit less than buprenorphine. The maximum inhibition by thienorphine on the intestinal transit was 50%-60%, whereas the maximum inhibition by morphine on gut transit was about 100%. Thienorphine also exhibited less inhibition on acetylcholine-induced contraction of GPI, with a maximum inhibition of 65%, compared with 93% inhibition by buprenorphine and 100% inhibition by morphine. Thienorphine induced a concentration-dependent decrease in the basal tonus of spontaneous movement of the GPI, the effect of which was weaker than that with buprenorphine. The duration of the effect of thienorphine on the GPI was longer than that with buprenorphine. CONCLUSION Thienorphine had less influence, but a longer duration of action on GPI contraction and moderately inhibited intestinal transit.

[1]  Juei-Tang Cheng,et al.  Opiate-induced constipation related to activation of small intestine opioid μ2-receptors. , 2012, World journal of gastroenterology.

[2]  R. N. Brogden,et al.  Buprenorphine: A Review of its Pharmacological Properties and Therapeutic Efficacy , 1979, Drugs.

[3]  M. Yamada,et al.  Muscarinic receptor subtypes mediating Ca2+ sensitization of intestinal smooth muscle contraction: studies with receptor knockout mice. , 2010, The Journal of veterinary medical science.

[4]  S. Yano,et al.  Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice. , 2007, European journal of pharmacology.

[5]  M. Ghosh Fundamentals of experimental pharmacology , 2007, Indian Journal of Pharmacology.

[6]  J. Traynor,et al.  Thienorphine: Receptor Binding and Behavioral Effects in Rhesus Monkeys , 2007, Journal of Pharmacology and Experimental Therapeutics.

[7]  Z. Gong,et al.  Thienorphine Is a Potent Long-Acting Partial Opioid Agonist: A Comparative Study with Buprenorphine , 2006, Journal of Pharmacology and Experimental Therapeutics.

[8]  Jian-hui Liang,et al.  A new buprenorphine analogy, thenorphine, inhibits morphine-induced behavioral sensitization in mice. , 2004, Acta pharmacologica Sinica.

[9]  K. Schuh,et al.  Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. , 1999, Drug and alcohol dependence.

[10]  Reese T. Jones,et al.  Bioavailability of Sublingual Buprenorphine , 1997, Journal of clinical pharmacology.

[11]  A. De Luca,et al.  Insights into opioid action in the intestinal tract. , 1996, Pharmacology & therapeutics.

[12]  H. Bhargava Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. , 1994, Pharmacological reviews.

[13]  I. McFadzean The ionic mechanisms underlying opioid actions , 1988, Neuropeptides.

[14]  C. Smith,et al.  Opioid receptors in the mouse ileum. , 1988, Archives internationales de pharmacodynamie et de therapie.

[15]  J. M. Crowder,et al.  Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes. , 1986, Biochemical pharmacology.

[16]  R. Macdonald,et al.  Dynorphin A decreases voltage‐dependent calcium conductance of mouse dorsal root ganglion neurones. , 1986, The Journal of physiology.

[17]  J. M. Crowder,et al.  Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices , 1986, British journal of pharmacology.

[18]  T. Matsumiya,et al.  Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations. , 1986, Japanese journal of pharmacology.

[19]  R. Macdonald,et al.  Dynorphin reduces voltage-dependent calcium conductance of mouse dorsal root ganglion neurons , 1984, Neuropeptides.

[20]  T. Burks,et al.  Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.

[21]  J. Szerb Correlation between acetylcholine release and neuronal activity in the guinea-pig ileum myenteric plexus; effect of morphine , 1982, Neuroscience.

[22]  H. Kosterlitz,et al.  Stereospecific increase by narcotic antagonists of evoked acetylcholine output in guinea-pig ileum. , 1975, Life sciences.

[23]  T. Burks Mediation by 5-hydroxytryptamine of morphine stimulant actions in dog intestine. , 1973, The Journal of pharmacology and experimental therapeutics.

[24]  H. Rang STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE. , 1964, British journal of pharmacology and chemotherapy.